Childhood Obesity: Wegovy Cuts BMI By 10% In Children As Young As 6; What Are The Risks?

Childhood Obesity: Wegovy Cuts BMI By 10% In Children As Young As 6; What Are The Risks?

Credit: AI Image

Text

Updated Nov 17, 2026 | 11:30 PM IST

SummaryNovo Nordisk led trial found that Wegovy reduced BMI by at least 10% in nearly 80% of children aged 6 to under 12 with obesity. However, limited long-term safety data and concerns about appetite suppression, nutritional intake and childhood development raise questions about the use of semaglutide in younger children.

End of Article